DAFTAR PUSTAKA

1.

World Health Organization. Global Status Report on Noncommunicable

Disease. Geneva: World Health Organization; 2014.

2.

World Health Organization. The Atlas of Heart Disease and Stroke. Geneva:
World Health Organization; 2004.

3.

Katritsis DG, Gersh BJ, and Camm AJ. Clinical Cardiolody Current Practice
Guidelines. England: Oxford University Press; 2013.

4.

Patterson C and Runge MS. Coronary Atherosclerosis. In: Runge MS,

Stouffer GA, and Patterson C, editors. Netters Cardiolody. 2 nd ed.
Philadelphia: Saunders Elsevier, 2010; p 15-21.

5.

Kim MC, Kini AS, and Fuster V. Definitions and Pathogenesis of Acute
Coronary Syndromes. In: Wals RA, Fang JC, and Fuster V, editors. Hursts
The Heart Manual of Cardiology. 13 th ed. New York: McGraw Hill
Companies, 2013; p. 249-257.

6.

World Health Organization. Prevention of Cardiovascular Disease: Pocket

Guidelines for Assesment and Management of Cardiovascular Risk. Geneva:
World Health Organization; 2007.

7.

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.

Tatalaksana Sindrom Koroner Akut. Jakarta: PERKI; 2015.

8.

Kones R. Primary Prevention of Coronary Heart Disease: Integration of New

Data, Evolving Views, Revised Goals, and Role of Rosuvastatin in
Management. Dove Press 2011;5:325-380.

9.

Lloyd-Jones DM, Hong Y, Labarthe D, et al. American Heart Association

Strategic Planning Task Force and Statistics Committee. Defining and Setting
National Goals for Cardiovascular Health Promotion and Disease Reduction:
The American Heart Associations Strategic Impact Goal Through 2020 and
Beyond. Circulation. 2010;121(4):586613.

Pedoman

10. Hall SL and Lorenc T. Secondary Prevention of Coronary Artery Disease.

American Familt Physician 2010;81(3):289-296.
11. Smith SC, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et
al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for

Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011

Update. Circulation 2011;124:2458-2473.
12. Balady GJ, Williams MA, Ades PA, et al. Core components of cardiac
rehabilitation/secondary prevention programs: 2007 update: a scientific
statement from the American Heart Association Exercise, Cardiac
Rehabilitation, and Prevention Committee, the Council on Clinical
Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and
Prevention, and Nutrition, Physical Activity, and Metabolism; and the
American Association of Cardiovascular and Pulmonary Rehabilitation.
Circulation 2007;115(20):2675-2682.
13. Domingo KB, Coxson P, Pletcher MJ, Lightwood J, and Goldman L.
Adolescent Overweight and Future Adult Coronary Heart Disease. NEJM
2007;357:2371-2379.
14. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer X, et al. Obesity
and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of
Weight Loss. Circulation 2006;113:898-918.
15. Mhnen MS, McElduff P, Dobson AJ, Kuulasmaa KA, and Evans AE.
Current Smoking and the Risk of Non-Fatal Myocardial Infarction in the
WHO MONICA Project Populations. Tob Control 2004;13(3):244250.
16. Bakhru A and Erlinger TP. Smoking Cessation and Cardiovasacular Disease
Risk Factors: Results from the third National Health and Nutrition
Examination Survey. PLoS Med 2005;2(6):e160.
17. Parikh P, McDaniel MC, Ashen D, Miller JI, Sorrentino M, Chan V, et al.
Diets and Cardiovascular Disease: an Evidance-Based Assessment.
JACC.2005;45(9):1379-1387
18. Walker C and Reamy BV. Diets for Cardiovascular Disease Prevention: What
Is the Evidance?. American Family Physician 2009;79(7):571-578.
19. Jakobsen MU, OReilly EJ, Heitmann BL, Pereira MA, Balter K, Fraser GE,
et al. Major Types of Dietary Fat and Risk of Coronary Heart Disease: A
Pooled Analysis of 11 Cohort Studies. Am J Clin Nutr 2009;89:1425-1432.
20. Oh K, Hu FB, Manson JE, Stampfer MJ, and Willett WC. Dietary Fat Intake
and Risk of Coronary Heart Disease in Woman: 20 Years of Follow-up of the
Nursess Health Study
21. Marmot M. Fruit and Vegetable Intake Reduces Risk of Fatal Coronary Heart
Disease. European Heart Journal 2011;32:1182-1183

22. Dauchet L, Amouyel P, Hercberg S, and Dallongville. Fruit and Vegetable

Consumption and Risk of Coronary Heart Disease: A Meta-Analysis of
Cohort Studies. J Nutr. 2006;136-2588-2593.
23. Wittstein IS. Depression, anxiety, and Platelet Reactivity in Patients with
Coronary Heart Disease. European Heart Journal 2010;31:1548-1550.
24. James PA, Oparil S, Carter BL, et al. 2014 evidance-based guideline for the
management of high blood pressure in adults report from the panel members
appointed to the eight joint national committee (JNC 8). JAMA 2014;284427.
25. American Diabetes Association. Glycemic Targets. Diabetes Care 2015;38
Suppl 1:S33-S40.
26. Ballantyne CM, Raichlen JS, Nicholls S, et al; ASTEROID Investigators.
Effect of rosuvastatin therapy on coronary artery stenoses assessed by
quantitative coronary angiography: a study to evaluate the effect of
rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.
Circulation. 2008;117(19):24582466.
27. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary
Prevention of Cardiovascular Disease and Stroke: 2002 Update. Circulation
2002;106:388-391.
28. Brugts JJ, Ninomiya T, Boersma E, et al. The Consistency of the Treatment
Effect of an ACE-inhibitor Based Treatment Regimen in Patients with
Vascular Disease or High Risk of Vascular Disease: a Combined Analysis of
Individual Data of ADVANCE, EUROPA, and PROGRESS trials. Eur Heart
J. 2009;30(11):1385-1394.